# Jasper Therapeutics, Inc.: Form 10-Q/A for the period ended Mar 31, 2021

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 10-Q/A
- Filed: 2021-07-23
- Accepted by EDGAR: Jul 22, 2021, 20:39 ET
- Period: 2021-03-31
- Accession: 0001213900-21-038236
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390021038236/f10q0321a2_amplitude.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390021038236/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390021038236/f10q0321a2_amplitude.htm

Filed Jul 23, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-038236. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
